Latest filing published 12 Aug 2026 for Ryan Specialty Holdings, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Henry S. Bienen, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Ryan Specialty Holdings, Inc., Traws Pharma, Inc. and First Albany Companies Inc. The record holds 41 filings, for trades running from 22 December 2006 to 10 August 2026.
No open-market sale appears; the market trades are 5 purchases worth €99k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 12 share grants and 1 option exercise.
The median purchase comes to €7,334.
On 12 August 2026 came the latest disclosure, a transaction in Ryan Specialty Holdings, Inc. The last insider purchase was made public on 31 May 2018, 3,068 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations